Sign in
Create a Profile
Galantamine to Enhance Cognitive Behavioral Therapy for Cocaine Abuse
Diseases and Conditions Researched
Cocaine Dependence
What is the purpose of this trial?
We are testing to see if Galantamine, a learning enhancing medication, will help methadone maintained cocaine abusers with their learning and memory specific to CBT using an innovative CBT computer program.
Participation Guidelines
Gender: Both
Click here for detailed participation information for this trial.
| Sponsors: | National Institute on Drug Abuse (NIDA); Yale University |
|---|---|
| Dates: | December 16, 2008 |
| Last Updated: | September 26, 2011 |
| Study HIC#: | 0708002943 |
| Clinicaltrials.gov ID: | NCT00809835 |
How will my information be used?
For more information about this trial, contact:
Dorothy Eagan, RN, MPH
203-386-8802
dorothy.eagan@yale.edu
Liz Doohan, BA
203-386-8802
elizabeth.doohan@yale.edu
Principal Investigator
Kathleen M Carroll, Ph.D.
How will my information be used?
When you express interest in a specific study, the information from your profile will be sent to the doctor conducting that study. If you're eligible to participate, you may be contacted by a nurse or study coordinator.
If you select a health category rather than a specific study, doctors who have active studies in that area may contact you to ask if you would like to participate.
In both cases, you will be contacted by the preferred method (email or phone) that you specified in your profile.
